New Times,
New Thinking.

  1. Culture
26 October 2011updated 27 Sep 2015 4:03am

Amy Winehouse: accidental alcohol poisoning

The singer was five times over the legal drink-drive limit when she died.

By Samira Shackle

Amy Winehouse died as an unintended consequence of drinking too much, an inquest into her death has heard.

Recording a verdict of “misadventure” — meaning that the death was accidental, not due to crime or negligence — the coroner said that the singer had 416mg of alcohol per 100ml in her blood, five times the legal driving limit of 80mg.

The pathologist who carried out the post-mortem told the court that a person with anything above 350mg in their blood can involuntarily stop breathing and fall into a coma. No illegal substances were found in her blood.

The court heard that Winehouse had abstained from alcohol for three weeks, but had hit the bottle again in the days before her death, despite being warned of the dangers. Her GP, Dr Christina Romete, told the inquest that the singer “did not want to die” and was “looking forward to the future”.

Select and enter your email address Your weekly guide to the best writing on ideas, politics, books and culture every Saturday. The best way to sign up for The Saturday Read is via saturdayread.substack.com The New Statesman's quick and essential guide to the news and politics of the day. The best way to sign up for Morning Call is via morningcall.substack.com
Visit our privacy Policy for more information about our services, how Progressive Media Investments may use, process and share your personal data, including information on your rights in respect of your personal data and how you can unsubscribe from future marketing communications.
THANK YOU

The 27-year-old singer, best known for her second album Back To Black, was found dead at her home in Camden, north London, on 23 July, after a well-documented battle with drugs and alcohol.

Content from our partners
How a digital approach to trade could empower economic growth
The UK’s skills shortfall is undermining growth
Unlocking investment in UK life sciences through manufacturing